Manejo clínico y programático de la tuberculosis con resistencia a fármacos

  • Peña M. C
  • Herrera M. T
  • Ruiz L. N
  • et al.
N/ACitations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

This publication summarizes part of the information provided during a training in multidrug resistant tuberculosis (MDR-TB) for clinical specialists in all health services of Chile with the collaboration of Dr. Jose Antonio Caminero Luna and the Chilean Program of Control and Eradication of Tuberculosis (PROCET). Emphasis was placed on early, sensitive and specific diagnostic methods of resistance to drugs based on molecular biology, showing some diagnostic algorithms feasible to implement in our country. Some proposals were made for changes in the treatment of tuberculosis with resistance to drugs, especially MDR-TB, with more effective therapeutic regimens recommended by the World Health Organization (WHO).

Cite

CITATION STYLE

APA

Peña M., C., Herrera M., T., Ruiz L., N., & Arias M., F. (2018). Manejo clínico y programático de la tuberculosis con resistencia a fármacos. Revista Chilena de Enfermedades Respiratorias, 34(2), 122–128. https://doi.org/10.4067/s0717-73482018000200122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free